Bleeding syndromes related to selective serotonin reuptake inhibitors (SSRIs). Seven case reports and literature review;Syndromes hemorragiques sous antidepresseurs inhibiteurs selectifs de la recapture de la serotonine (ISRS). Propos de sept cas et revue de la litterature

Revue de Medecine Interne

Volumn 21, Issue 2, 2000, Pages 152-160

  Nelva, A ^a   Guy, C ^a   Tardy Poncet, B ^a   Beyens, M N ^a   Ratrema, M ^a   Benedetti, C ^a   Ollagnier, M ^a  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

Bleeding; Bleeding time; Platelet aggregation; Selective serotonin selective inhibitor

Indexed keywords

FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; BLEEDING DISORDER; BLEEDING TIME; CLINICAL ARTICLE; DRUG SURVEILLANCE PROGRAM; FEMALE; HEMATOMA; HUMAN; MALE; SEX DIFFERENCE; THROMBOCYTE AGGREGATION INHIBITION; CASE REPORT; CHEMICALLY INDUCED DISORDER; GASTROINTESTINAL HEMORRHAGE; MIDDLE AGED; NEWBORN; PREGNANCY; PRENATAL EXPOSURE; REVIEW;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMATOMA; HEMORRHAGE; HUMANS; INFANT, NEWBORN; MALE; MIDDLE AGED; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0033974049     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(00)88244-2     Document Type: Article

References (33)

1. Kramer P. Listening to Prozac- First. Documents. Paris : Éditions générales First ; 1993.
2. Humphries JE, Wheby MS, Vandenberg SR. Fluoxetine and the bleeding time. Arch Pathol Lab Med 1990 ; 114 : 727-8.
3. Canadian Adverse Drug Reaction Newsletter : communiqué. Arch Pathol Lab Med 1997 ; 4 : 953-4.
4. Yaryura-Tobias JA, Kirschen H, Ninan P, Mosberg HJ. Fluoxetine and bleeding in obsessive compulsive disorder. Am J Psychiatry 1991 ; 148 : 949.
5. Mhanna MJ, Bennet JB, Izatt SB. Potential fluoxetine chloride (Prozac®) toxicity in a newborn. Pediatrics 1997 : 100 : 158-9.
6. Leung M, Shore L. Fluvoxamine associated bleeding. Can J Psychiatry 1996 ; 41 : 604-5.
7. Alderman CP, Moritz CK, Ben-Tovim DI. Abnormal platelet agregation associated with fluoxetine therapy. Ann Pharmacother 1992 ; 26 : 1517-9.
8. Wilmshurst PT, Kumar AV. Subhyaloid haemorrage with fluoxetine. Eye 1996 ; 10 : 141.
9. Evans TG, Buys SS, Rodgers GM. Acquired abnormalities of platelet function. N Engl J Med 1991 ; 324 : 1671.
10. Ottervanger JP, Stricker BH, Huls J, Weeda JN. Bleeding attributed to the intake of serotonine paroxetine. Am J Psychiatry 1994 ; 151 : 781-2.
11. e éd. Paris : Éditions Inserm.
12. Skop BP. Brown TM. Potential vascular and bleeding complications of treatment with sérotonine reuptake inhibitors. Psychosomatics 1996 ; 37 : 12-6.
13. Allain P. Sérotonine, sérotoninomimétiques. antagonistes. In : Pharmacologie. Paris : Estem ; 1996.
14. Seghers A. Rôle de la sérotonine dans les conduites agressives et impulsives : pour une stratégie thérapeutique au-delà de l'urgence. Rev Fr Psychiatr Psychol Méd 1997 ; 4 : 110-4.
15. Fillion G. Comportement des récepteurs 5-HT lors d'un traitement anti-dépresseur au long cours et à l'arrêt. Encéphale 1995 ; 21 Suppl. 1 : 3-6.
16. Daprada M, Cesuraa M, Launay M, Richards JG. Platelet as a model for neurones? Experientia 44. Basel: Birlhauser Verlag: 1998. p. 115-26.
17. Trzeciak MC, Vinciguerra C. Bordet JC. Physiologie et exploration de l'hémostase et de la thrombose : hémostase primaire. Encycl Méd Chir (Elsevier. Paris). Hématologie, 13-019-A-10. 1997.
18. Declerck FF, Herman AG. 5-Hydroxytryptamine and platelet agregation. Federation Proc 1983 ; 42 : 228-32.
19. Hantouche E. Génération sérotonine. Synapse 1992 ; 82 : 17-24.
20. Mardsen CA, Tyrer P. Casey P, Seivewright N. Changes in human whiole blood 5-HT and platelet 5-HT uptake during with paroxetine, a selective 5-HT uptake inhibitor. J Psychopharmacol 1987 ; 1 : 244-50.
21. Ortiz. J. Artigas fluoxetine. Effects of monoamine uptake inhibitors on extracellullar and platelet 5-hydroxytryptamine in rat blood: different effects of clomipramine ann lfuoxetine. Br J Pharmacol 1992 : 105 : 941-6.
22. Menys VC, Smith CCT, Lewins P, Framer RDT. Noble MIM. Platelet 5-HT is decreased in a preliminary group of depressed patients receiving the 5-Htre-uptake inhibiting drug fluoxetine. Clin Sci 1996 ; 91 : 87-92.
23. Berk M, Jacobson BJ, Hurly E. Fluoxetine and hemostatic function: a pilot study. J Clin Psychiatry 1995 ; 56 : 14-6.
24. Laine-Cessac P. Shoaay I, Garre JB, Glaud V. Turcant A, Allain P. Study of haemostasis in depressive patients treated with fluoxetine. Pharmacoepidemiol Drug Saf 1998 ; 7 : 54-7.
25. Cattaneo M, Pareti FI, Zighetti M, Lecchi A, Lombardi R, Manucci PM. Platelet aggregation at high shear is impaired in patients with congenital defects of platelet secretion and is corrected by DDAVP. Correlation with the bleeding time. J Lab Clin Med 1995 : 125 : 540-47.
26. Cerrito F, Lazzaro MP, Gaudio E, Arminio P. Aloisi G. 5-HT2 receptors and serotonin release: their role in human platelet agregation. Life Sci 1993 ; 53 : 209-15.
27. Tielens J. Vitamin C for paroxetine and fluvoxamine associated bleeding. Am J Psychiatry 1997 : 153 : 883-4.
28. Gunzberger DW, Martinez D. Adverse vascular effects associated with fluoxetine. Am J Psychiatry 1992 : 149 : 1751.
29. Calhoun JW. Prolonged bleeding time in a patient treated with sertraline. Am J Psychiatry 1996 : 1533 : 443.
30. Stanford MS, Patton JH. In: Utero exposure to fluoxetine Hcl increases hematoma freaquency at birth. Pharmacol Biochem Behav 1993 ; 45 : 959-62.
31. Pai VB, Kelly MW. Bruising associated with the use of fluoxetine. Ann Pharmacother 1996 ; 30 : 786-8.
32. Cooper TA, Valcour VG. Gibbson RB, O'Brien-Falls K. Spontaneous ecchymoses due to paroxetine administration. Am J Med 1998 ; 104 : 197-8.
33. Aranth J, Lindberg C. Bleeding, a side effect of fluoxetine. Am J Psychiatry 1992 : 149 : 412-3.